
    
      The study is To evaluate clinical and peri-procedural angiographic outcomes for the SYNERGYTM
      MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System in the treatment of
      subjects with atherosclerotic lesion(s) ≤34 mm in length (by visual estimate) in native
      coronary arteries ≥2.25 mm to ≤4.0 mm in diameter (by visual estimate).
    
  